21 Nov
|
Mammoth Biosciences
|
London
21 Nov
Mammoth Biosciences
London
Lead LNP process scale-up at Mammoth Biosciences, applying MSAT expertise to technology transfer, process characterization, and PPQ readiness. The role supports Phase 2 and late-stage clinical manufacturing.
As Director, Manufacturing Science and Technology, you will own the technical path from the Phase 1 clinical process to a scalable process. You will work with CDMOs, contract labs, and internal Process Development, Quality, Regulatory CMC, Supply Chain, and Program Management teams.
The position builds through external resources before establishing an internal MSAT function.
Key Responsibilities:
- Lead LNP process scale-up through Phase 2 and late-stage clinical scale
- Define equipment, mixing scalability, scale-down, and comparability strategies
- Execute technology transfers with development partners and GMP CDMOs
- Build QbD control strategies linking CQAs, CPPs, and material attributes
- Lead PPQ planning, execution, reporting, and continued process verification transition
Requirements:
- PhD and 10+ years, MS and 14+, or BS and 16+ years
- 6+ years in MSAT, process development, or technical operations
- 3+ years leading parenteral drug product programs
- Hands-on LNP or comparable complex parenteral scale-up experience
- Completed process characterization and PPQ campaign experience
Direct Mammoth’s LNP scale-up, technology transfer, process characterization, and PPQ readiness across external manufacturing partners.
#J-18808-Ljbffr
📌 Director MSAT LNP Process Scale-Up (London)
🏢 Mammoth Biosciences
📍 London